Nahuel Simonet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nahuel Simonet has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ece Naz Bilgiç
Ecole Polytechnique Federale de Lausanne (EPFL), School of Life Sciences, Brain Mind Institute, EpiGN—NeuroNA Chair in Epigenomics of Neurodevelopmental Disorders, Station 19, Lausanne, Switzerland
1 shared publication - Fides Zenk
Ecole Polytechnique Federale de Lausanne (EPFL), School of Life Sciences, Brain Mind Institute, EpiGN—NeuroNA Chair in Epigenomics of Neurodevelopmental Disorders, Station 19, Lausanne, Switzerland
1 shared publication - Hanrong Hu
Ecole Polytechnique Federale de Lausanne (EPFL), School of Life Sciences, Brain Mind Institute, EpiGN—NeuroNA Chair in Epigenomics of Neurodevelopmental Disorders, Station 19, Lausanne, Switzerland
1 shared publication Heather Murray
Ecole Polytechnique Federale de Lausanne (EPFL), School of Life Sciences, Brain Mind Institute, EpiGN—NeuroNA Chair in Epigenomics of Neurodevelopmental Disorders, Station 19, Lausanne, Switzerland
1 shared publicationMarkus Rechsteiner
Universitätsspital Zürich, Zürich, Switzerland
1 shared publicationRegina Reimann
Universitätsspital Zürich, Zürich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A scalable Tn5-based method for genome-wide DNA methylation profiling in development and disease
DNA methylation is a key epigenetic modification involved in development and disease, including cancer, and serves as a biomarker for diagnosis. Current detection methods, such as bisulfite sequencing, provide base-pair resolution but require high sequencing depth and cost. Here, we developed C me CUT&Tag, a Tn5-based approach that uses methylation-binding domain fusion proteins to selectively target methylated DNA in chromatinized and isolated DNA. This enables adapter insertion into methylated regions, allowing low-depth sequencing for quantitative analysis or optional cytosine conversion for base-pair resolution. C me CUT&Tag enables genome-wide DNA methylation profiling with reduced input and sequencing requirements. We demonstrate its performance in characterizing DNA methylation across development and disease in human stem cells, organoids, zebrafish embryogenesis, and tumor biopsies. The method shows strong concordance with bisulfite sequencing and supports the classification of brain tumor samples into methylation subtypes. These features make C me CUT&Tag a scalable and cost-effective approach for epigenetic research and potential clinical applications.
- 22 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA scalable Tn5-based method for genome-wide DNA methylation profiling in development and disease
DNA methylation is a key epigenetic modification involved in development and disease, including cancer, and serves as a biomarker for diagnosis. Current detection methods, such as bisulfite sequencing, provide base-pair resolution but require high sequencing depth and cost. Here, we developed C me CUT&Tag, a Tn5-based approach that uses methylation-binding domain fusion proteins to selectively target methylated DNA in chromatinized and isolated DNA. This enables adapter insertion into methylated regions, allowing low-depth sequencing for quantitative analysis or optional cytosine conversion for base-pair resolution. C me CUT&Tag enables genome-wide DNA methylation profiling with reduced input and sequencing requirements. We demonstrate its performance in characterizing DNA methylation across development and disease in human stem cells, organoids, zebrafish embryogenesis, and tumor biopsies. The method shows strong concordance with bisulfite sequencing and supports the classification of brain tumor samples into methylation subtypes. These features make C me CUT&Tag a scalable and cost-effective approach for epigenetic research and potential clinical applications.